Chemical Works of Gedeon Richter (BUD:RICHTER) Beta: N/A (As of Jul. 08, 2026)


BUD:RICHTER Chemical Works of Gedeon Richter PLC BUD:RICHTER
100 GF Score
Price Ft12,280.00
GF Value Ft11,218.63
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Chemical Works of Gedeon Richter Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-08), Chemical Works of Gedeon Richter's Beta is Not available.

Chemical Works of Gedeon Richter  (BUD:RICHTER) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Chemical Works of Gedeon Richter Beta Related Terms

Chemical Works of Gedeon Richter Beta Historical Data

* Premium members only.

The historical data trend for Chemical Works of Gedeon Richter's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemical Works of Gedeon Richter Beta Chart

Chemical Works of Gedeon Richter Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Chemical Works of Gedeon Richter Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BUD:RICHTER
100GF Score
Chemical Works of Gedeon Richter PLC BUD:RICHTER
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemical Works of Gedeon Richter Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Chemical Works of Gedeon Richter (BUD:RICHTER) Overvalued in 2026?

Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued. The current stock price of Ft12,280.00 is trading 9.5% above its estimated GF Value™ of Ft11,218.63. GuruFocus considers Chemical Works of Gedeon Richter to be Fairly Valued.

Key valuation signals for BUD:RICHTER:

  • Beta: N/A
  • GF Value™: Ft11,218.63 vs. price of Ft12,280.00 (9.5% above fair value)
  • GF Score™: 100/100 with 5 warning signs

No single metric tells the full story. See the BUD:RICHTER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chemical Works of Gedeon Richter Business Description

Address Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
100GF Score

Get the complete analysis for BUD:RICHTER

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft12,280.00
Price
Ft11,218.63
GF Value